Journal
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
Volume 75, Issue 5, Pages 539-556Publisher
WILEY
DOI: 10.1111/aji.12492
Keywords
CD33; decidua; human pregnancy; immune tolerance; MDSC
Categories
Funding
- Interdisciplinary Center for Clinical Research (IZKF) Wurzburg [A-169]
Ask authors/readers for more resources
ProblemHuman pregnancy needs a remarkable local immune tolerance toward the conceptus. Myeloid-derived suppressor cells (MDSC) are important players promoting cancer initiation and progression by suppressing T-cell functions and thus inducing immune tolerance. Therefore, MDSC were expected within decidua. MethodsSubpopulations of CD33(+) immune cells were isolated from human early pregnancy decidua and characterized phenotypically and functionally by microscopy, FACS analysis, RT-PCR, Western blotting and in the coculture with T cells. ResultsDecidua harbors CD33(+)/HLA-DRneg and CD33(+)/HLA-DR+/- cells which both express arginase, iNOS and IDO and a typical cytokine profile. Both subtypes potently suppress T-cell proliferation and therefore fulfill the criteria of MDSC. ConclusionWe characterized a new population of CD33(+)/HLA-DRneg and CD33(+)/HLA-DR+/- cells in human early pregnancy decidua with properties of classical MDSC and thus potentially being an important player in immune tolerance in pregnancy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available